Decreased release of glutathione into the systemic circulation of patients with HIV infection

European Journal of Clinical Investigation

Volumn 26, Issue 1, 1996, Pages 38-44

  Helbling, B ^a   Von Overbeck, J ^a   Lauterburg, B H ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Cysteine; Cysteinylglycine; Glutathione; HIV infection; Pharmacokinetics

Indexed keywords

CYSTEINE; GLUTATHIONE;

ADULT; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; PHARMACOKINETICS; PRIORITY JOURNAL;

EID: 0030043194     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.1996.88237.x     Document Type: Article

References (44)

1. Buhl R, Holroyd KJ, Mastrangeli A et al. Systemic glutathione deficiency in symptom-free HIV-seropositive individuals. Lancet. 1989;II:1294-8.
2. Eck HP, Gmuender H, Hartmann M, Petzoldt D, Daniel V, Droege W. Low concentrations of acid-soluble thiol (cysteine) in the blood plasma of HIV-1 infected patients. Biol Chem Hoppe Seyler. 1989;370:101-8.
3. Roederer M, Staal FJT, Anderson M, Rabin R, Raju PA, Herzenberg LA. Disregulation of leukocyte glutathione in AIDS. Ann N Y Acad Sci. 1991;677:113-25.
4. Staal FJT, Roederer M, Israelski DM et al. Intracellular glutathione levels in T cell subsets decrease in HIV-infected individuals. AIDS Res Hum Retroviruses. 1992;8:305-11.
5. Hamilos DL, Wedner HJ. The role of glutathione in lymphocyte activation. I. Comparison of inhibitory effects of buthionine sulfoximine and 2-cyclohexene-1-one by nuclear size transformation. J Immunol 1985;135:2740-7.
6. Smyth MJ, Glutathione modulates activation-dependent proliferation of human peripheral blood lymphocyte populations without regulating their activated function. J Immunol 1991:146:1921-7.
7. Eck HP, Stahl-Hennig C, Hunsmann G, Droege W. Metabolic disorder as early consequence of simian immunodeficiency virus infection in rhesus macaques. Lancet. 1991;338:346-7.
8. Kalebic T, Kinter A, Poli G, Anderson ME, Meister A, Fauci AS. Suppression of human immunodeficiency virus expression in chronically infected monocytic cells by glutathione, glutathione ester, and N-acetylcysteine. Proc Natl Acad Sci USA 1991;88:986-90.
9. Staal FJT, Roederer M, Herzenherg LA. Intracellular thiols regulate activation of nuclear factor kappa-B and transcription of human immunodeficiency virus. Proc Natl Acad Sci USA 1990;87:9943-7.
10. Wu J, Levy E, Black PH. Mercaptoethanol and N-acetylcysteine enhance T cell colony formation in AIDS and ARC. Clin Exp Immunol 1989;77:7-10.
11. Roederer M, Staal FJT, Raju PA, Ela SW, Herzenberg LA. Cytokine-stimulated human immunodeficiency virus replication is inhibited by N-acetyl-L-cysteine. Proc Natl Acad Sci USA 1990;87:4884-8.
12. Staal FJT, Roederer M, Raju PA, Anderson MT, Ela SW, Herzenberg LA. Antioxidants inhibit stimulation of HIV transcription, AIDS Res Hum Retroviruses 1993;9:299-306.
13. Halliwell B, Cross CE. Reactive oxygen species, antioxidants, and acquired immunodeficiency syndrome sense or speculation. Arch Intern Med 1991;151:29-31.
14. Staal FJT, Ela SW, Roederer M, Anderson MT, Herzenberg LA. Glutathione deficiency and human immunodeficiency virus infection. Lancet 1992;339:909-12.
15. Roederer M, Staal FJT, Ela SW, Herzenberg LA. N-acetylcysteine: potential for AIDS therapy. Pharmacology 1993;46:121-9.
16. Droege W, Eck HP, Mihm S. HIV-induced cysteine deficiency and T-cell dysfunction a rationale for treatment with N-acetylcysteine. Immunol Today 1992;13:211-14.
17. Lahdevirta J, Maury CP, Teppo AM, Repo H. Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome. Am J Med. 1988;85: 289-91.
18. 2. J Clin Invest 1992;89:794-802.
19. Zimmerman RJ, Marafino BJJ, Chan A, Landre P, Winkelhake JL. The role of oxidant injury in tumor cell sensitivity to recombinant human tumor necrosis factor in rivo. Implications for mechanisms of action. J Immunol 1989;142:1405-09.
20. Adams JD, Lauterburg BH, Mitchell JR. Plasma glutathione and glutathione disulfide in the rat: regulation and response to oxidative stress. J Pharmacol Exp Ther 1983;227:749-54.
21. Eck HP, Mertens T, Rosokat H et al. T4+ cell numbers are correlated with plasma glutamate and cystine levels: association of hyperglutamataemia with immunodeficiency in diseases with different aetiologies. Int Immunol 1992;4:7-13.
22. Eck HP, Droege W. Influence of the extracellular glutamate concentration on the intracellular cyst(e)ine concentration in macrophages and the capacity to release cysteine. Biol Chem Hoppe-Seyler 1989;370:109-13.
23. Gmuender H, Eck HP, Benninghoff B, Roth S, Droege W. Macrophages regulate intracellular glulathione levels of lymphocytes. Evidence for an immunoregulatory role of cysteine. Cell Immunol 1990;129:32-46.
24. DeQuay B, Malinverni R, Lauterburg BH. Glutathione depletion in HIV-infected patients: role of cysteine deficiency and effect of oral N-aectylcysteine. AIDS 1992;6:815-19.
25. Lauterburg BH, Adams JD, Mitchell JR. Hepatic glutathione homeostasis in the rat: Efflux accounts for glutathione turnover. Hepatology 1984;4:586-90.
26. Reed D, Orrenius S. The role of methionine in glutathione biosynthesis by isolated hepatocytes. Biochem Biophys Res Commun 1977;77:1258-64.
27. Anderson ME, Meister A. Dynamic state of glutathione in blood plasma. J Biol Chem 1980;255:9530-3.
28. Stofer-Vogel B, Cerny T, Kuepfer A, Junker E, Lauterburg BH. Depletion of circulating cyst(e)ine by oral and intravenous mesna. Br J Cancer 1993;68:590-3.
29. Mansoor MA, Svardal AM, Ueland PM. Determination of the in vivo redox status of cysteine, cysteinylglycine, homocysteine, and glutathione in human plasma. Anal Biochem 1992;200:218-29.
30. Stofer-Vogel B, Cerny T, Borner M, Lauterburg BH. Oral bioavailability of mesna tablets. Cancer Chemother Pharmacol. 1993;32:78-81.
31. Bidlingmeyer BA, Cohen SA, Tarvin TL. Rapid analysis of amino acids using pre-column derivatization. J Chromatogr 1984;336:93-104.
32. Burgunder JM, Lauterburg BH. Decreased production of glutathione in patients with cirrhosis. Eur J Clin Invest 1987;17:408-14.
33. Hahn RW. The fate of extracellular glutathione in the rat. Biochim Biophys Acta 1978;539:324-37.
34. Poulsen HE, Vilstrup H, Almdal T, Dalhoff K. No net splanchnic release of glutathione in man during N-acetylcysteine infusion. Scand J Gastroenterol 1993;28:408-12.
35. Purucker E, Wernze H. Hepatic efflux and renal extraction of plasma glutathione - marked differences between healthy subjects and the rat. Klin Wochenschrift 1990;68:1008-12.
36. Cho ES, Sahyoun N, Stegink LD. Tissue glutathione as a cyst(e)ine reservoir during fasting and refeeding of rats. J Nutr 1981;111:914-22.
37. Higashi T, Tateishi N, Naruse A, Sakamoto Y. A novel physiological role of liver glutathione as a reservoir of L-cysteine. J Biochem 1977;82:117-24.
38. Acbi S, Assereto R, Lauterburg BH. High dose intravenous glutathione in man. Pharmacokinetics and effects on cyst(e)ine in plasma and urine. Eur J Clin Invest 1991;21:103-10.
39. Sies H, Summer KH. Hydroperoxide metabolizing systems in rat liver. Eur J Biochem. 1975;57:503-12.
40. Richman PG, Meister A. Regulation of gamma glutamylcysteine synthetase by nonallosteric feedback inhibition by glutathione. J Biol Chem 1975;250:1422-6
41. Lauterburg BH, Vaishnav Y, Stillwell WG, Mitchell JR. The effects of age and glulathione depletion on hepatic glutathione turnover in vivo determined by acetaminophen probe analysis. J Pharmacol Exp Ther 1980;213:54-8.
42. Beloqui O, Prieto J, Suarez M et al. N-acetyl cysteine enhances the response to interferon-alpha in chronic hepatitis-C - a pilot study. J Interferon Res 1993;13:279-82.
43. Witschi A, Junker E, Schranz C, Speck RF, Lauterburg BH. Supplementation of N-acetylcysteine fails to increase glutathione in lymphocytes and plasma of patients with AIDS. AIDS Res Hum Retroviruses 1995;11:141-3.
44. Levy EJ, Anderson ME, Meister A. Transport of glutathione diethyl ester into human cells. Proc Natl Acad Sci USA 1993;90:9171-5.